Css LLC Amylyx Pharmaceuticals, Inc. Transaction History
Css LLC
- $972 Million
- Q2 2025
A detailed history of Css LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Css LLC holds 31,700 shares of AMLX stock, worth $435,558. This represents 0.04% of its overall portfolio holdings.
Number of Shares
31,700Holding current value
$435,558% of portfolio
0.04%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AMLX
# of Institutions
151Shares Held
76.1MCall Options Held
212KPut Options Held
40.6K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.8MShares$121 Million0.1% of portfolio
-
Perceptive Advisors LLC New York, NY7.9MShares$109 Million2.22% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$81.7 Million7.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.54MShares$62.3 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$61.8 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $804M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...